Lataa...
In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2
Neurofibromatosis type 2 (NF2) is an autosomal-dominant disorder affecting about 1:33 000 newborns, mainly characterized by the development of tumors of the nervous system and ocular abnormalities. Around 85% of germline NF2 mutations are point mutations. Among them, ∼25% affect splicing and are ass...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3722955/ https://ncbi.nlm.nih.gov/pubmed/23188051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2012.261 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|